Evaluation of the Toxicity of Sugammadex in Zebrafish Larvae
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Woon Young | - |
dc.contributor.author | Kim, Yeon-Hwa | - |
dc.contributor.author | Lee, Ji Yoon | - |
dc.contributor.author | Kim, Jae Hwan | - |
dc.contributor.author | Min, Too Jae | - |
dc.date.accessioned | 2021-08-31T08:04:27Z | - |
dc.date.available | 2021-08-31T08:04:27Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-03-09 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/57309 | - |
dc.description.abstract | Background: Sugammadex is a new neuromuscular blockade reversal agent. Recently, it has been used in patients under general anesthesia. However, sugammadex could be toxic to fetuses and pediatric patients under 3 years of age. In this study, we demonstrated the safety of sugammadex in fetuses, using zebrafish larvae. Furthermore, its neurotoxicity was evaluated using neuronal cell lines. Methods: We used SH-SY5Y cells to determine the viability of neuronal cells treated with sugammadex. Zebrafish larvae were used to determine the teratogenic effects of sugammadex. Results: Sugammadex showed no adverse effects on neuronal cells and zebrafish larvae. The survival rates of neuronal cells were not different in all concentrations. In addition, the heart formation of zebrafish embryos, which were exposed to various concentrations of sugammadex, were not different. Conclusion: This study demonstrated the feasibility of using sugammadex during pregnancy. However, further clinical studies will be required to extrapolate these results to humans. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | INDUCED NEUROMUSCULAR BLOCKADE | - |
dc.subject | REVERSAL | - |
dc.subject | NEOSTIGMINE | - |
dc.subject | EFFICACY | - |
dc.subject | SAFETY | - |
dc.subject | AGENT | - |
dc.title | Evaluation of the Toxicity of Sugammadex in Zebrafish Larvae | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Woon Young | - |
dc.contributor.affiliatedAuthor | Kim, Jae Hwan | - |
dc.contributor.affiliatedAuthor | Min, Too Jae | - |
dc.identifier.doi | 10.3346/jkms.2020.35.e51 | - |
dc.identifier.scopusid | 2-s2.0-85081528335 | - |
dc.identifier.wosid | 000519579400004 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.35, no.9 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 35 | - |
dc.citation.number | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002565895 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | INDUCED NEUROMUSCULAR BLOCKADE | - |
dc.subject.keywordPlus | REVERSAL | - |
dc.subject.keywordPlus | NEOSTIGMINE | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordPlus | AGENT | - |
dc.subject.keywordAuthor | Sugammadex | - |
dc.subject.keywordAuthor | Toxicity | - |
dc.subject.keywordAuthor | Zebrafish | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.